Key result
Cryo-electron microscopy structures of SARS-CoV-2 nsp10-nsp14 with an RNA substrate reveal the molecular determinants of ExoN substrate specificity and mismatch correction during viral RNA synthesis.
Why the study?
SARS-CoV-2 ExoN undermines nucleotide analog antivirals by excising them, making structural insights into its mismatch recognition critical for antiviral design.
The study reveals the structural basis of mismatch recognition by the SARS-CoV-2 proofreading enzyme, providing guidance for the rational design of improved anticoronavirus therapies.
Cryo-EM structures of coronavirus ExoN may guide antiviral design; leaves open clinical translation for nucleotide analogs.
Coronavirus 3′-to-5′ exoribonuclease (ExoN), residing in the nonstructural protein (nsp) 10–nsp14 complex, boosts replication fidelity by proofreading RNA synthesis and is critical for the virus life cycle. ExoN also recognizes and excises nucleotide analog inhibitors incorporated into the nascent RNA, undermining the effectiveness of nucleotide analog–based antivirals. Here we present cryo–electron microscopy structures of both wild-type and mutant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nsp10-nsp14 in complex with an RNA substrate bearing a 3′-end mismatch at resolutions ranging from 2.5 to 3.9 angstroms. The structures reveal the molecular determinants of ExoN substrate specificity and offer insight into the molecular mechanisms of mismatch correction during coronavirus RNA synthesis. Our findings provide guidance for rational design of improved anticoronavirus therapies.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2021) studied SARS-CoV-2. Cryo-EM structural analysis was evaluated on Cryo-EM structure resolution and biochemical cleavage activity. Cryo-electron microscopy structures of SARS-CoV-2 nsp10-nsp14 with an RNA substrate reveal the molecular determinants of ExoN substrate specificity and mismatch correction during viral RNA synthesis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: